Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery.
Saved in:
| Title: | Emerging Trends in the Application of Nanosuspension-Based Biomaterials for Anticancer Drug Delivery. |
|---|---|
| Authors: | Aldeeb MME; Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.; Department of Pharmaceutics, Faculty of Pharmacy, Elmergib University, Alkhoms, 40414, Libya., Wilar G; Department of Pharmacology and Clinical Pharmacy, Faculty of, Universitas PadjadjaranPharmacy, Jatinangor, 45363, Indonesia., Suhandi C; Doctoral Program of Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia.; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia., Mohammed AFA; Department of Pharmaceutics, Faculty of Pharmacy, Minia University, Minia, 61517, Egypt., Mahmoud SA; Center for Scientific Research and Entrepreneurship, Northern Border University, Arar, 73213, Saudi Arabia., Elamin KM; Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan., Wathoni N; Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, 45363, Indonesia. |
| Source: | International journal of nanomedicine [Int J Nanomedicine] 2025 Jul 01; Vol. 20, pp. 8587-8607. Date of Electronic Publication: 2025 Jul 01 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
